To determine if ATRX mutations associate with inflammatory signaling pathways in glioma patients, we first performed gene set enrichment analysis (GSEA) on TCGA bulk RNAseq data from IDH1-mutant low-grade gliomas (LGG). The gene discussed is ATRX; the disease is central nervous system cancer.